Discusses translation-reprogramming strategies as alternatives to dual-AAV gene replacement for treating rare large-gene disorders and sensory loss.
Key Takeaways
- Delineates a breakthrough in the treatment of inherited hearing loss through gene therapy
- Bespoke cell and gene therapy approach is revolutionizing precision medicine for genetically diverse diseases
- This gene was linked to hereditary deafness in 1999 by Christine Petit’s group